These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3024756)

  • 1. Characterization of the inhibition of tissue factor in serum.
    Broze GJ; Miletich JP
    Blood; 1987 Jan; 69(1):150-5. PubMed ID: 3024756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
    Sanders NL; Bajaj SP; Zivelin A; Rapaport SI
    Blood; 1985 Jul; 66(1):204-12. PubMed ID: 3873968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.
    Rao LV; Rapaport SI
    Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor.
    Ploplis VA; Edgington TS; Fair DS
    J Biol Chem; 1987 Jul; 262(20):9503-8. PubMed ID: 3496335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa.
    Callander NS; Rao LV; Nordfang O; Sandset PM; Warn-Cramer B; Rapaport SI
    J Biol Chem; 1992 Jan; 267(2):876-82. PubMed ID: 1730676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Higuchi DA; Wun TC; Likert KM; Broze GJ
    Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII.
    Ruf W; Miles DJ; Rehemtulla A; Edgington TS
    J Biol Chem; 1992 Nov; 267(31):22206-10. PubMed ID: 1429572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
    van 't Veer C; Golden NJ; Mann KG
    Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells and the activation of factor VII.
    Rao LV; Rapaport SI
    Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.